Related Links:
Physician Search
Search VCU




The Department of Pathology at Virginia Commonwealth University

Charles V. Clevenger, MD, PhD

These are transformative and exciting times for the discipline of Pathology and the Department of Pathology at Virginia Commonwealth University. Driving this transformation are advances in molecular diagnosis, informatics, biobanking, translational/personalized medicine, and market shifts to a value-based practice model.  As a primary provider of healthcare diagnosis, we seek to lead rather than be driven by change.

The evidence of how we are meeting these challenges is manifest by the investments that are being made in the physical and intellectual capital of the department. This spring 2013 a $1.5 million dollar build of a state-of-the-art autopsy suite was completed, and the planning for the renovation of the department’s 25,000 net square foot research and administrative space was initiated. Our molecular diagnostics unit is offering whole exome sequencing, while our microbiology section is utilizing both molecular approaches and mass spectroscopy for rapid organism identification and drug sensitivity testing. New faculty hires in hematology, microbiology, and dermatopathology in 2013 have enhanced our clinical mission and the onboarding of two breast cancer biology labs represent the beginning of a major basic research expansion of the Department of Pathology.

The Department of Pathology is a diverse clinical, research, and teaching department within the School of Medicine at Virginia Commonwealth University Medical Center, located in Richmond, Virginia. We offer a full range of pathology services to physicians, researchers, and patients at the Medical College of Virginia Hospital, a 780-bed tertiary-care urban teaching hospital dedicated to serving the patients and physicians of central Virginia.

We have 33 full-time Pathology faculty based at the MCV Campus and four additional faculty based at the Hunter Holmes McGuire Veterans' Affairs Hospital. Currently, 14 Residents and seven Fellows are in our training programs. Our post-graduate programs are comprehensive and integrated, offering outstanding career preparation. Many of our trainees go on to complete academic fellowships.

Within the department, there are 14 clinical laboratories including Histopathology, Neuropathology, Cytopathology, Autopsy Pathology, Molecular Diagnostics, Cytogenetics, Hematology, Coagulation, Microbiology, Immunology, Clinical Chemistry, Toxicology, and Transfusion Medicine. Our clinical laboratories are staffed by 296 full-time equivalent hospital employees who perform more than 2.6 million billable tests this year. 

Our scientists are supported by numerous research grants, primarily from NIH, with extramural funding in excess of $1.2 million in 2012. We have funded research programs in molecular diagnostics, liver disease, hepatobiliary cancer, infectious disease, obesity, diabetes, and breast cancer. There is also a wide variety of clinical and applied research in all areas of pathology and laboratory medicine. 

You are invited to visit our website and learn more about our programs, our people, and how we seek to transform Pathology and the practice of medicine. We welcome you to be a part of the exciting times that lie ahead in Richmond.


Charles V. Clevenger, MD, PhD
Chair, Department of Pathology
Carolyn Wingate Hyde Professor in Cancer Biology